Search

Get to know Abby Hawk, who got a tattoo of Memorial Sloan Kettering after being treated there for neuroblastoma.

… Friday, September 10, 2021 VIDEO | 00:04 Abby Leaves Her Mark Abby's tattoo shows the latitude and longitude of Memorial Sloan Kettering Cancer Center and the quote "The comeback is always stronger than the setback." Video Details It was a bold request. A high school senior living outside Toledo named

A lifelong smoker overcomes discomfort over what a lung cancer imaging test might reveal. She hopes her experience helps reduce the stigma for others who smoke.

… Thursday, September 19, 2024 Marylou Capes-Platt knew she was at an especially high risk for lung cancer . She had been a heavy smoker for 45 years, starting in her teens and continuing through a decades-long career in the music industry and as a writer and editor. She finally quit in 2007. But the threat

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

… Tuesday, April 30, 2013 Summary Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide. Targeted therapies hold promise for the treatment of many types of cancer. But a common predicament is that in many patients

The treatment that children receive for retinoblastoma can lead to health problems later in life. A new study documents their frequency and extent.

… Monday, February 1, 2016 Summary Retinoblastoma  is a rare childhood cancer that affects the eyes. It is highly treatable but can result in long-term medical consequences. A study conducted by MSK researchers documents the type and frequency of these consequences among survivors. The results will inform

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, November 2, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Mijin Kim Named A 2023 STAT Wunderkind Mijin Kim, PhD Mijin Kim, PhD , postdoctoral fellow, has been  honored   among the 2023 STAT Wunderkinds. STAT Wunderkinds acknowledges

Membership is a widely accepted mark of excellence in science and considered one of the highest honors a scientist can receive.

… Tuesday, April 28, 2020 Two Sloan Kettering Institute (SKI) researchers have been elected to the National Academy of Sciences (NAS). Scott Keeney, PhD , a molecular biologist, and Christopher Lima, PhD , a structural biologist, join more than a dozen Memorial Sloan Kettering investigators who are already

Visible Ink at Memorial Sloan Kettering Cancer Center (MSK) is the leading — and largest — writing program of its kind. Writing promotes creativity, reduces stress, and empowers people with cancer to give voice to their stories.

… Friday, April 6, 2018 Visible Ink at Memorial Sloan Kettering Cancer Center (MSK) is the leading — and largest — writing program of its kind. Writing promotes creativity, reduces stress, and empowers people with cancer to give voice to their stories. On Monday, April 16 at 6:30 p.m. , the Kaye Playhouse

Dr. Perales was formally sworn in during the 2023 Tandem Transplantation and Cellular Therapy Meetings of ASTCT and the Center for International Blood and Marrow Transplant Research (CIBMTR) on February 18.

… Monday, February 20, 2023 Miguel-Angel Perales, MD , of Memorial Sloan Kettering Cancer Center (MSK), has been named President of The American Society for Transplantation and Cellular Therapy (ASTCT) for 2023-2024. Dr. Perales was formally sworn in during the 2023 Tandem Transplantation and Cellular

Memorial Sloan Kettering Cancer Center (MSK) today celebrated the opening of a $1.5 billion state-of-the-art cancer treatment facility with government officials, members of the Boards of Overseers and Managers, and staff. Opening for patient care next month, the 750,000-square-foot building is the institution’s — and the city’s — largest freestanding cancer care facility. The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is a healing community dedicated to patient-centered care, made possible by a landmark donation and a pioneering vision that signifies a new era of cancer care.

… Tuesday, December 10, 2019 Memorial Sloan Kettering Cancer Center (MSK) today celebrated the opening of a $1.5 billion state-of-the-art cancer treatment facility with government officials, members of the Boards of Overseers and Managers, and staff. Opening for patient care next month, the 750,000-square-foot

Learn why post-doctoral researcher Mijin Kim believes Memorial Sloan Kettering is an excellent choice for early career biomedical researchers, as she enjoys her recognition as a STAT Wunderkind, class of 2023.

… Tuesday, October 17, 2023 Mijin Kim, PhD, a postdoctoral researcher at Memorial Sloan Kettering Cancer Center (MSK), has been recognized with the prestigious  Wunderkind award by STAT , the well-regarded news site covering science and medicine. Each year, STAT seeks to find “the best researchers in health